DOPAMINE RECEPTOR LIGANDS AND THERAPEUTIC METHODS BASED THEREON

摘要

The present invention relates to compounds designed as ligands (e.g., agonists, antagonists, and partial agonists) for dopamine receptors (e.g., D1, D2, D3, D4, and D5), and in particular, the D1, D2, and D3 dopamine receptors. The present invention also relates to methods for rationally designing these compounds and to therapeutic methods of using these compounds.